PRASCO 327 (Phenylephrine and guaifenesin SR 30 mg / 900 mg)
Pill imprint PRASCO 327 has been identified as Phenylephrine and guaifenesin SR 30 mg / 900 mg.
Guaifenesin/phenylephrine is used in the treatment of cough and nasal congestion; sinus symptoms and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 30 mg / 900 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for PRASCO 327 (Phenylephrine and guaifenesin SR 30 mg / 900 mg)
More about guaifenesin/phenylephrine
- Guaifenesin/phenylephrine controlled-release tablets
- Guaifenesin/phenylephrine liquid
- Guaifenesin/phenylephrine suspension
- Guaifenesin/phenylephrine sustained-release capsules
- More (2) »